ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT

Go back to ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Sarepta Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SRPT
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 20.81 +0.67 (3.33%)
Previous Close $20.14    52 Week High $63.73 
Open $20.46    52 Week Low $8.00 
Day High $21.19    P/E N/A 
Day Low $20.19    EPS $-5.69 
Volume 2,192,048